COO
The Cooper Companies·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About COO
The Cooper Companies, Inc.
A global, consumer-centric medical device company
Healthcare Equipment and Supplies
--
09/26/2023
NASDAQ Stock Exchange
16,000
10-31
Common stock
6101 Bollinger Canyon Road, Suite 500, San Ramon, California, 94583
--
The Cooper Companies, Inc., a Delaware corporation founded in 1980, is a global medical device company listed on the New York Stock Exchange. The company is a global manufacturer of products for contact lens wearers. The company develops, produces and sells a wide range of disposable, bi-weekly and monthly contact lenses using advanced materials and optical components. The company designs its products to address vision challenges such as astigmatism, presbyopia, myopia, dry eyes and eye fatigue; extensive collection of spherical, complex and multifocal contact lenses.
Earnings Call
Company Financials
EPS
COO has released its 2025 Q4 earnings. EPS was reported at 1.15, versus the expected 1.11, beating expectations. The chart below visualizes how COO has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
COO has released its 2025 Q4 earnings report, with revenue of -1.96B, reflecting a YoY change of -5.57%, and net profit of -205.70M, showing a YoY change of -30.77%. The Sankey diagram below clearly presents COO's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available

